Cingulate Inc. (NASDAQ:CINGW – Get Free Report) was the recipient of a large drop in short interest during the month of October. As of October 15th, there was short interest totaling 1 shares, a drop of 99.9% from the September 30th total of 864 shares. Based on an average trading volume of 22,414 shares, the days-to-cover ratio is currently 0.0 days.
Cingulate Trading Down 62.8%
Shares of Cingulate stock opened at $0.00 on Wednesday. Cingulate has a 1 year low of $0.00 and a 1 year high of $0.12. The company has a 50 day simple moving average of $0.01 and a two-hundred day simple moving average of $0.03.
About Cingulate
Cingulate Inc is a clinical-stage biopharmaceutical company developing treatments for central nervous system disorders. The company is focused on its Precision Timed Release (PTR) drug-delivery platform, which is designed to deliver multiple doses of medication at specific times from a single dosage form.
Cingulate’s lead program, CTx-1301, is an investigational extended-release formulation of dexmethylphenidate intended to treat attention-deficit/hyperactivity disorder (ADHD). The company has also pursued CTx-1302, an investigational treatment candidate for anxiety disorders.
Recommended Stories
- Five stocks we like better than Cingulate
- Taiwan Semiconductor Flexes Pricing Power on AI’s Frontline
- Hidden in Plain Sight: 2 Earnings Winners Investors May Have Missed
- These 3 New ETFs Are Turning Heads—Are They Worth Buying?
- Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength
Receive News & Ratings for Cingulate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cingulate and related companies with MarketBeat.com's FREE daily email newsletter.
